Sharma, S. P.
Hirsch, A.
Hunink, M. G. M.
Cramer, M. J. M.
Mohamed Hoesein, F. A. A.
Geluk, C. A.
Kramer, G.
Gratama, J. W. C.
Braam, R. L.
van der Zee, P. M.
Yassi, W.
Wolters, S. L.
Gürlek, C.
Pundziute, G.
Vliegenthart, R.
Budde, R. P. J. http://orcid.org/0000-0003-3792-615X
Funding for this research was provided by:
Zorginstituut Nederland
HeartFlow Inc.
Article History
Accepted: 12 May 2022
First Online: 17 August 2022
Conflict of interest
: S.P. Sharma, A. Hirsch, M.G.M. Hunink, M.J.M. Cramer, F.A.A. Mohamed Hoesein, C.A. Geluk, G. Kramer, J.W.C. Gratama, R.L. Braam, P.M. van der Zee, W. Yassi, S.L. Wolters, C. Gürlek, G. Pundziute, R. Vliegenthart and R.P.J. Budde declare that they have no competing interests. This study is financially supported by HeartFlow, Inc. In addition, the Erasmus Medical Centre has received support from HeartFlow, Inc. and Siemens for other studies unrelated to the FUSION trial.